Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2026-06-13 @ 8:23 PM
Study NCT ID:
NCT02648204
Status:
COMPLETED
Last Update Posted:
2019-10-15
First Post:
2016-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
Sponsor:
Novo Nordisk A/S
Organization: